TECHNOLOGY
NEWS
CAREERS
CONTACT
HOME
TECHNOLOGY
NEWS
CAREERS
CONTACT
简体中文
Industry-leading platform for RNA-targeted therapy
READ MORE
LATEST NEWS
R&D Progress | ODD Is Granted by US FDA to RecoRNA’s RC001
R&D Progress | ODD Is Granted by US FDA to RecoRNA’s RC001
R&D Progress | ODD Is Granted by US FDA to RecoRNA’s RC001
2025-04-23
11:39:50
Recently, RC001, RecoRNA’s independently developed drug candidate targeting specific neurological disease, was successfully granted for Orphan Drug Designation (ODD) by the U.S. Food and Drug Administ...
Recently, RC001, RecoRNA’s independently developed drug candidate targeting specific neurological di...
Recently, RC001, RecoRNA’s independe...
READ MORE
RECORNA BIO and BeiGene Bioisland Innovation Center Join Hands to Explore a New Chapter in RNA Therapy | Press Release
RECORNA BIO and BeiGene Bioisland Innovation Center Join Hands to Explore a New Chapter in RNA Therapy | Press Release
RECORNA BIO and BeiGene Bioisland Innovation Center Join Hands to Explore a New Chapter in RNA Therapy | Press Release
2024-04-19
08:00:00
On April 15, 2024, at the strategic signing ceremony for 'Innovation-driven, collaborative development', RECORNA BIO and BeiGene Innovation Center announced that an in-depth collaboration has been rea...
On April 15, 2024, at the strategic signing ceremony for 'Innovation-driven, collaborative developme...
On April 15, 2024, at the strategic ...
READ MORE
Outstanding Honor Roll| RECORNA Bio Wins the "Best Innovative Pharmaceutical Company of 2023" Award
Outstanding Honor Roll| RECORNA Bio Wins the "Best Innovative Pharmaceutical Company of 2023" Award
Outstanding Honor Roll| RECORNA Bio Wins the "Best Innovative Pharmaceutical Company of 2023" Award
2023-08-19
06:00:02
On August 18, 2023, Haoyue Capital, a leading investment firm focusing on China's healthcare industry, released its "Seventh Annual list for Outstanding Healthcare Investment". RECORNA Bio w...
On August 18, 2023, Haoyue Capital, a leading investment firm focusing on China's healthcare industr...
On August 18, 2023, Haoyue Capital, ...
READ MORE
BeiGene Bioisland Innovation Center (BIC) in Guangzhou, No.31, Xinghan 2nd Road, Guangzhou International Bioisland, Huangpu District, Guangzhou
1W Phase One, Hong Kong Science Park Pak Shek Kok New Territories Hong Kong
RECORNA@recornabio.com
info@xuxin.recornabio.com
official account
